2
Participants
Start Date
October 21, 2015
Primary Completion Date
April 30, 2019
Study Completion Date
January 24, 2020
Eribulin
Intravenous eribulin administered on days 1 and 8 of a 21-day cycle.
Irinotecan
Irinotecan will be administered orally at a fixed dose of 90 mg/m2/day on days 1 -5 of a 21-day cycle.
Cefixime
Cefixime will be given to all patients to reduce irinotecan-associated diarrhea. It will be administered Day -1 through Day 8 of each cycle.
University of Kentucky, Lexington
Children's Hospital Colorado, Aurora
University of Texas, Southwestern Medical Center, Dallas
University of Kentucky
OTHER
University of Colorado, Denver
OTHER